*The population prevalence of AS is estimated at 1:12,000-1:24,000 [Mertz et al 2013].
Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic Workflow [Godler et al 2022].
It is estimated that over 500,000 individuals are living with Angelman syndrome worldwide, yet only a small portion of these individuals have been identified. Your community can help us ensure that opportunities for access to education, support, and community resources are available to all individuals living around the world with Angelman syndrome.
We are seeking to partner with patient organisations and/or ambassadors in countries without a dedicated Angelman syndrome organisation. Contact us for more details.
The following countries are represented by ambassadors.
To enquire about becoming an ambassador or to contact an ambassador please contact us.
*The population prevalence of AS is estimated at 1:12,000-1:24,000 [Mertz et al 2013].
Feasibility of Screening for Chromosome 15 Imprinting Disorders in 16 579 Newborns by Using a Novel Genomic Workflow [Godler et al 2022].